Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE

European Journal of Human Genetics

Volumn 15, Issue 8, 2007, Pages 823-830

  Graham, Robert R ^a   Ortmann, Ward ^b   Rodine, Peter ^b   Espe, Karl ^b   Langefeld, Carl ^c   Lange, Ethan ^c   Williams, Adrienne ^c   Beck, Stephanie ^c   Kyogoku, Chieko ^b   Moser, Kathy ^b   Gaffney, Patrick ^b   Gregersen, Peter K ^d   Criswell, Lindsey A ^e   Harley, John B ^f   Behrens, Timothy W ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; LA ANTIBODY; RO ANTIBODY; SM ANTIBODY;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR2 ANTIGEN; HLA-DR3 ANTIGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RISK ASSESSMENT;

EID: 34547182875     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201827     Document Type: Article

References (55)

1. Hochberg MC, Perlmutter DL, Medsger TA et al: Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995; 4: 454-456.
2. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME: Surviving the butterfly and the wolf: Mortality trends in systemic lupus rythematosus. Autoimmun Rev 2004; 3: 423-453.
3. Hochberg MC: The epidemiology of systemic lupus erythematosus; in: Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus. Williams and Wilkins: Baltimore, 1997; 49-65.
4. Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397-408.
5. Nath SK, Kilpatrick J, Harley JB: Genetics of human systemic lupus erythematosus: The emerging picture. Curr Opin Immunol 2004; 16 794-800.
6. Gaffney PM, Moser KL, Graham RR, Behrens TW: Recent advances in the genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 2002; 28: 111-126.
7. Deapen DM, Escalante A, Weinrib L, Horwitz DA, Mack TM: A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311-318.
8. Hochberg M, Florsheim P, Scott J, Arnett FC: Familial aggregation of systemic lupus erythematosus. Arthritis Rheum 1985; 28: 523.
9. Goldberg MA, Arnett FC, Bias WB, Shulman LE: Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum 1976; 19: 129-132.
10. Prokunina L, Castillejo-Lopez C, Oberg F et al: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666-669.
11. Kyogoku C, Langefeld CD, Ortmann WA et al: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504-507.
12. Aguado B, Bahram S, Beck S et al: Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401 921-923.
13. Rhodes DA, Trowsdale J: Genetics and molecular genetics of the MHC. Rev Immunogenet 1999; 1: 21-31.
14. Snell GD: Methods for the study of histocompatibility genes. J Genet 1948; 49: 87.
15. Vyse TJ, Todd JA: Genetic analysis of autoimmune disease. Cell 1996; 85: 311-318.
16. Reichlin M, Harley JB: Antibodies to Ro/SSA and La/SSB; In: Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus. Lippincott Williams & Wilkins: Philadelphia, PA, 2002, pp 467-480.
17. Reveille JD: Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus 2004; 13: 290-297.
18. Arbuckle MR, McClain MT, Rubertone MV et al: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
19. Harley JB, Moser KL, Gaffney PM, Behrens TW: The genetics of human systemic lupus erythematosus. Curr Opin Immunol 1998; 10: 690-696.
20. Tan FK, Arnett FC: The genetics of lupus. Curr Opin Rheumatol 1998; 10: 399-408.
21. Graham RR, OrtmannWA, Langefeld CD et al: Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71: 543-553.
22. Meyer O, Hauptmann G, Tappeiner G, Ochs HD, Mascart-Lemone F: Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol 1985; 62: 678-684.
23. Hartung K, Ehrfeld H, Lakomek HJ et al: The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE study group. Rheumatol Int 1992; 11 243-249.
24. Gaffney PM, Kearns GM, Shark KB et al: A genome-wide search for susceptibility genes in human systemic lupus erythematosus sibpair families. Proc Natl Acad Sci USA 1998; 95: 14875-14879.
25. Gaffney PM, Ortmann WA, Selby SA et al: Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000; 66: 547-556.
26. Graham RR, Langefeld CD, Gaffney PM et al: Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus. Arthritis Res 2001; 3: 299-305.
27. Moser KL, Neas BR, Salmon JE et al: Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-14874.
28. Moser KL, Gray-McGuire C, Kelly J et al: Confirmation of genetic linkage between human systemic lupus erythematosus and chromosome 1q41. Arthritis Rheum 1999; 42: 1902-1907.
29. Seligman VA, Suarez C, Lum R et al: The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. Arthritis Rheum 2001; 44: 618-625.
30. Parsa A, Peden E, Lum RF et al: Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: Analysis of 644 SLE families. Genes Immun 2002; S42-S46.
31. Jawaheer D, Li W, Graham RR et al: Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002; 71: 585-594.
32. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
33. Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D: The New York Cancer Project: Rationale, organization, design, and baseline characteristics. J Urban Health 2004; 81: 301-310.
34. Lee HS, Li W, Lee A et al: Microsatellite typing for DRB1 alleles: application to the analysis of HLA associations with rheumatoid arthritis. Genes Immun 2006; 7: 533-543.
35. Clark G, Reichlin M, Tomasi Jr TB: Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 1969; 102: 117-122.
36. Ramos PS, Kelly JA, Gray-McGuire C et al: Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immunol 2006; 7: 417-432.
37. Spielman RS, Ewens WJ: A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test. Am J Hum Genet 1998; 62: 450-458.
38. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
39. Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER: Genotype-based association test for general pedigrees: The genotype-PDT. Genet Epidemiol 2003; 25: 203-213.
40. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
41. Hall FC, Weeks DE, Camilleri JP et al: Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Qjm 1996; 89: 821-829.
42. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA: The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1148.
43. Barcellos LF, Oksenberg JR, Begovich AB et al: HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003; 72: 710-716.
44. Harley JB, Alexander EL, Bias WB et al: Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 1986; 29: 196-206.
45. Hamilton RG, Harley JB, Bias WB et al: Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496-505.
46. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M: A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum 1989; 32: 826-836.
47. Fujisaku A, Frank MB, Neas B, Reichlin M, Harley JB: HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 1990; 86: 606-611.
48. Hughes AL, Yeager M: Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998; 32: 415-435.
49. Parham P, Ohta T: Population biology of antigen presentation by MHC class I molecules. Science 1996; 272: 67-74.
50. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA: Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11: 85-89.
51. McClain MT, Poole B, Bruner BF, Kaufman KM, Harley JB, James JA: An altered immune response to Epstein-Barr virus nuclear antigen-1 (EBNA-1) in pediatric systemic lupus erythematosus. Arthrit Rheum 2006; 54: 360-368.
52. Paust S, Cantor H: Regulatory T cells and autoimmune disease. Immunol Rev 2005; 204: 195-207.
53. Arnett FC: The genetic basis of lupus erythematosus; in: Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus. Williams & Wilkins: Baltimore, 1997, pp 77- 117.
54. Harley JB, Moser KL, Gaffney PM, Behrens TW: The genetics of human systemic lupus erythematosus. Curr Opin Immunol 1998; 10: 690-696.
55. Walsh EC, Mather KA, Schaffner SF et al: An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003; 73: 580-590.